Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial

PRISM-2 Investigators

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds